Green tea extract as a treatment for patients with wild-type transthyretin amyloidosis: an observational study
Fabian aus dem Siepen,1 Ralf Bauer,1 Matthias Aurich,1 Sebastian J Buss,1 Henning Steen,1 Klaus Altland,2 Hugo A Katus,1 Arnt V Kristen1 1Department of Cardiology, Angiology, and Respiratory Medicine, University Hospital Heidelberg, Heidelberg, Germany; 2Institute of Human Genetics, Justus-Liebig-U...
Main Authors: | aus dem Siepen F, Bauer R, Aurich M, Buss SJ, Steen H, Altl, K, Katus HA, Kristen AV |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-12-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/green-tea-extract-as-a-treatment-for-patients-with-wild-type-transthyr-peer-reviewed-article-DDDT |
Similar Items
-
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner
by: Morie Gertz, et al.
Published: (2020-09-01) -
Cardiac function in hereditary transthyretin amyloidosis : an echocardiographic study
by: Arvidsson, Sandra
Published: (2016) -
A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosis
by: Teresa Coelho, et al.
Published: (2020-07-01) -
A Clinical Case of the Hereditary Transthyretin Amyloidosis
by: E. V. Reznik, et al.
Published: (2021-05-01) -
Urinary Transthyretin as a Biomarker in ATTRv Val50Met Amyloidosis
by: Ando, Y., et al.
Published: (2022)